Single dose of fast-acting psychedelic nasal spray shows promise for stubborn depression
A single dose of a toad‑venom nasal spray cuts depression symptoms in early trials, sparking global health interest.
3 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 3 separate news trends connected to Psychedelic Therapy, spanning June 26, 2026 through October 28, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 25 article observations and 23 source signals, led by Health coverage. Use it to compare how individual events emerged, spread and changed over time.
A single dose of a toad‑venom nasal spray cuts depression symptoms in early trials, sparking global health interest.
A major randomized clinical trial indicates that psilocybin, the active compound in magic mushrooms, provides relief for treatment-resistant depression.
An 80-year-old woman with Alzheimer's has regained speech and mobility after taking psilocybin.